Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.
Guardado en:
Autores principales: | Harry O. Orlans, Michelle E. McClements, Alun R. Barnard, Cristina Martinez-Fernandez de la Camara, Robert E. MacLaren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transient tractional retinal detachment in an eye with retinitis pigmentosa
por: Shuichiro Hirahara, et al.
Publicado: (2010) -
Retinitis pigmentosa is associated with shifts in the gut microbiome
por: Oksana Kutsyr, et al.
Publicado: (2021) -
Unilateral retinitis pigmentosa and cone-rod dystrophy
por: Donald F Farrell
Publicado: (2009) -
Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa
por: Logan Ganzen, et al.
Publicado: (2021) -
Association of retinal vessel attenuation with visual function in eyes with retinitis pigmentosa
por: Nakagawa S, et al.
Publicado: (2014)